Oncotelic Therapeutics (OTLC) EBITDA (2010 - 2021)
Oncotelic Therapeutics' EBITDA came in at -$1.5 million for Q4 2021, compared with -$3.24 million a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) EBITDA (2010 - 2021) Analysis & Trends
For FY2021, Oncotelic Therapeutics' EBITDA was -$9.06 million.
- Going back by year, EBITDA was -$7.22 million in FY2020, -$4.25 million in FY2019, -$676,549 in FY2018 and -$13.83 million in FY2017.
- The Q4 2021 figure represents the highest quarterly EBITDA since Q2 2020.
- Business Quant data shows OTLC's EBITDA at -$1.79 million (Q3 2021), -$3.75 million (Q2 2021) and -$2.02 million (Q1 2021) in the three quarters before Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Oncotelic Therapeutics | 5.77 Mn | 4.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -1.11 Mn |
| Sep 30, 2021 | -1.47 Mn |
| Jun 30, 2021 | -3.43 Mn |
| Mar 31, 2021 | -1.60 Mn |
| Dec 31, 2020 | -3.51 Mn |
| Sep 30, 2020 | -1.29 Mn |
| Jun 30, 2020 | 171,396.00 |
| Mar 31, 2020 | -1.41 Mn |
| Dec 31, 2018 | -141,816.00 |
| Sep 30, 2018 | -201,192.00 |
| Jun 30, 2018 | -144,747.00 |
| Mar 31, 2018 | -793,000.00 |
| Dec 31, 2017 | -2.43 Mn |
| Sep 30, 2017 | -3.54 Mn |
| Jun 30, 2017 | -3.89 Mn |
| Mar 31, 2017 | -3.97 Mn |
| Dec 31, 2016 | -3.47 Mn |
| Sep 30, 2016 | -3.26 Mn |
| Jun 30, 2016 | -3.66 Mn |
| Mar 31, 2016 | -3.35 Mn |
API Access
Oncotelic Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();